NFA
ANAC

Nationwide Fund Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Nationwide Fund Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-34,773
Closed -$1.88M – 3429
2016
Q1 		$1.88M Buy
34,773
+562
+2% +$41.5K 0.01% 1379
2015
Q4 		$3.87M Buy
34,211
+52
+0.2% +$5.73K 0.02% 1064
2015
Q3 		$4.02M Sell
34,159
-2,429
-7% -$317K 0.02% 1026
2015
Q2 		$2.83M Sell
36,588
-2,398
-6% -$157K 0.01% 1252
2015
Q1 		$2.25M Sell
38,986
-804
-2% -$34.1K 0.01% 1402
2014
Q4 		$1.28M Sell
39,790
-224
-0.6% -$6.72K 0.01% 1679
2014
Q3 		$979K Buy
40,014
+14,761
+58% +$300K ﹤0.01% 1844
2014
Q2 		$448K Buy
+25,253
New +$407K ﹤0.01% 2322
2014
Q1 		– Sell
-19,523
Closed -$328K – 3359
2013
Q4 		$328K Sell
19,523
-698
-3% -$9.66K ﹤0.01% 2446
2013
Q3 		$215K Buy
20,221
+4,427
+28% +$38.7K ﹤0.01% 2618
2013
Q2 		$88K Buy
+15,794
New +$95.6K ﹤0.01% 2839

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Nationwide Fund Advisors's ANAC Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 34,773 shares — an estimated $1.88M sold.

Nationwide Fund Advisors first reported a position in ANAC in Q2 2013 and held it in 11 quarters. The position peaked at $4.02M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Nationwide Fund Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Nationwide Fund Advisors sold 34,773 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.88M.
  • Nationwide Fund Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 11 quarters.
  • Nationwide Fund Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $4.02M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.